CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Vecuronium Bromide

维库溴铵 杂质对照品Vecuronium Bromide Impurities

EP19 个杂质条目19 impurity entries

本页汇总 维库溴铵 的 19 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 19 impurity reference standards of Vecuronium Bromide with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 维库溴铵(Vecuronium Bromide)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability indicating liquid chromatography method for the analysis of Vecuronium bromide: study of the degradation profile
    Heliyon · 2020 · Abd Elrahman MK et al.  ·  PMID 32195388  ·  DOI
  2. 分析方法Analytical MethodsDetermination of muscle relaxants pancuronium and vecuronium bromide by capillary electrophoresis with capacitively coupled contactless conductivity detection
    Electrophoresis · 2011 · Petrů K et al.  ·  PMID 21394728  ·  DOI
  3. 分析方法Analytical MethodsStability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2007 · Johnson CE, Cober MP  ·  PMID 17989445  ·  DOI
  4. 分析方法Analytical MethodsMass spectrometric assay for determination of pancuronium and vecuronium in biological fluids utilizing the moving belt introduction system
    Biomedical & environmental mass spectrometry · 1990 · Baker TR et al.  ·  PMID 1968351  ·  DOI

维库溴铵 —— 原料药与杂质对照品Vecuronium Bromide — drug substance & impurities

共 20 个条目(含原料药本体)20 items incl. the drug substance
Vecuronium Bromide structure
EP原料药 APIAPI
维库溴铵Vecuronium Bromide
Vecuronium Bromide
CAS No.50700-72-6
Chemical FormulaC34H57BrN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 1 (Vecuronium Bromide EP Impurity A) structure
EPA
维库溴铵杂质1 (维库溴铵EP杂质A)Vecuronium Bromide Impurity 1 (Vecuronium Bromide EP Impurity A)
Vecuronium Bromide Impurity 1 (Vecuronium Bromide EP Impurity A)
CAS No.13529-31-2
Chemical FormulaC33H54N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 2 (Vecuronium Bromide EP Impurity B Dibromide) structure
EPB
维库溴铵杂质2 (维库溴铵EP杂质B 二溴化物)Vecuronium Bromide Impurity 2 (Vecuronium Bromide EP Impurity B Dibromide)
Vecuronium Bromide Impurity 2 (Vecuronium Bromide EP Impurity B Dibromide)
CAS No.15500-66-0
Chemical FormulaC35H60N2O42+·2Br-
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 3 (Vecuronium Bromide EP Impurity C Bromide) structure
EPC
维库溴铵杂质3 (维库溴铵EP杂质C 溴化物)Vecuronium Bromide Impurity 3 (Vecuronium Bromide EP Impurity C Bromide)
Vecuronium Bromide Impurity 3 (Vecuronium Bromide EP Impurity C Bromide)
CAS No.73319-13-8
Chemical FormulaC32H55N2O3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 4 (Vecuronium Bromide EP Impurity D Bromide) structure
EPD
维库溴铵杂质4 (维库溴铵EP杂质D 溴化物)Vecuronium Bromide Impurity 4 (Vecuronium Bromide EP Impurity D Bromide)
Vecuronium Bromide Impurity 4 (Vecuronium Bromide EP Impurity D Bromide)
CAS No.73319-30-9
Chemical FormulaC30H53N2O2+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 5 (Vecuronium Bromide EP Impurity E Bromide) structure
EPE
维库溴铵杂质5 (维库溴铵EP杂质E 溴化物)Vecuronium Bromide Impurity 5 (Vecuronium Bromide EP Impurity E Bromide)
Vecuronium Bromide Impurity 5 (Vecuronium Bromide EP Impurity E Bromide)
CAS No.50587-95-6
Chemical FormulaC32H55N2O3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 6 (Vecuronium Bromide EP Impurity F) structure
EPF
维库溴铵杂质6 (维库溴铵EP杂质F)Vecuronium Bromide Impurity 6 (Vecuronium Bromide EP Impurity F)
Vecuronium Bromide Impurity 6 (Vecuronium Bromide EP Impurity F)
CAS No.18668-29-6
Chemical FormulaC26H41NO3
Purity>95%询价On request
10mg25mg50mg100mg
2
维库溴铵杂质2Vecuronium Bromide Impurity 2
Vecuronium Bromide Impurity 2
CAS No.211936-13-9
Chemical FormulaC19H27BrO
Purity>95%现货In stock
10mg25mg50mg100mg
Vecuronium Bromide Impurity 7 structure
7
维库溴铵杂质7Vecuronium Bromide Impurity 7
Vecuronium Bromide Impurity 7
CAS No.13522-14-0
Chemical FormulaC29H48N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 11 structure
11
维库溴铵杂质11Vecuronium Bromide Impurity 11
Vecuronium Bromide Impurity 11
CAS No.13522-16-2
Chemical FormulaC29H50N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 12 structure
12
维库溴铵杂质12Vecuronium Bromide Impurity 12
Vecuronium Bromide Impurity 12
CAS No.50588-27-7
Chemical FormulaC33H54N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 13 structure
13
维库溴铵杂质13Vecuronium Bromide Impurity 13
Vecuronium Bromide Impurity 13
CAS No.53357-31-6
Chemical FormulaC31H52N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 14 structure
14
维库溴铵杂质14Vecuronium Bromide Impurity 14
Vecuronium Bromide Impurity 14
CAS No.50588-23-3
Chemical FormulaC31H50N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 15 structure
15
维库溴铵杂质15Vecuronium Bromide Impurity 15
Vecuronium Bromide Impurity 15
CAS No.119328-63-1
Chemical FormulaC29H50N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 16 structure
16
维库溴铵杂质16Vecuronium Bromide Impurity 16
Vecuronium Bromide Impurity 16
CAS No.13522-24-2
Chemical FormulaC31H52N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 17 structure
17
维库溴铵杂质17Vecuronium Bromide Impurity 17
Vecuronium Bromide Impurity 17
CAS No.119302-70-4
Chemical FormulaC31H52N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 18 structure
18
维库溴铵杂质18Vecuronium Bromide Impurity 18
Vecuronium Bromide Impurity 18
CAS No.119302-68-0
Chemical FormulaC31H52N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 19 structure
19
维库溴铵杂质19Vecuronium Bromide Impurity 19
Vecuronium Bromide Impurity 19
CAS No.74395-85-0
Chemical FormulaC24H37NO2
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 20 structure
20
维库溴铵杂质20Vecuronium Bromide Impurity 20
Vecuronium Bromide Impurity 20
CAS No.50587-93-4
Chemical FormulaC32H53N2O3+·Br-
Purity>95%询价On request
10mg25mg50mg100mg
Vecuronium Bromide Impurity 21 structure
21
维库溴铵杂质21Vecuronium Bromide Impurity 21
Vecuronium Bromide Impurity 21
CAS No.981-49-7
Chemical FormulaC24H39NO2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

维库溴铵 —— 研究文献与合成路线Vecuronium Bromide — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 维库溴铵 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Vecuronium Bromide. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating liquid chromatography method for the analysis of Vecuronium bromide: study of the degradation profile
    Abd Elrahman MK, El Houssini OM, Fahem DK, et al. · Heliyon · 2020 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. Synthesis process of vecuronium bromide
    HONG JIANG, SHUJIANG TU, SHUNLIN GU, YUFANG CHEN · 公开号 CN101684139CN101684139 · 2010
  2. Novel vecuronium bromide freeze-dried preparation and preparation method thereof
    TAO CHEN, HUIJING HU, RUTAO WANG, WEIJIAO WANG · 公开号 CN101843593CN101843593 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

维库溴铵 杂质谱研究要点Vecuronium Bromide — impurity profiling notes

下面这些是拿到 维库溴铵 的 20 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 20 impurity entries for Vecuronium Bromide, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances